AXONEXPO 2019: ASA devices at the forefront

04 April 2019 - Trade fairs & Congresses -

The ASA devices for MLS® Laser Therapy and Hilterapia® were among the main protagonists of the fourth edition of the “AxonExpo 2019” fair in Lille (22-23 March, Davo Pévèle Arena- Orchies).

“The event – explains Roberto Terruzzi, ASA’s Senior Export Area Manager – is organised every year in France by our partner Axone for the human sector and represents a valid occasion for providing visibility of our products to potential customers and to meet once again professionals who have already chosen us, thus becoming the main spokespersons for our therapeutic approach”.

The ASA stand, which also included a room for technical testing, showcased M6, Mphi 5, HIRO 3.0 and SH1 and gained the attention of visitors interested in discovering effective therapies for the patient and for improving their performance, thanks also to their design.

You might also be interested in ...

See all articles

news - 15/02/2018
Asalaser’s internationalisation strategy is also achieved through training. A tangible example of this is given by the first Advanced MLS® course which was held on 7th February in the...
news - 11/10/2017
The M6, Mphi 5, Mphi, Easy Qs and Hiro 3.0 devices were the real stars of the stand set up by ASAlaser and Axone, the distributor for France, f
news - 05/04/2017
The ties between MLS® therapies and the French market are getting increasingly closer: in fact, a strenuous day of training dedicated to MLS® Laser Therapy was scheduled at the Axone...
MLS Laser Therapy for TMD
Blog - 22/10/2025
A recent publication from Chulalongkorn University (Thailand) demonstrated how an integrated and conservative approach, supported by MLS® Laser Therapy, can offer highly effective clinical results.
M-Hi laser training UK
News - 22/10/2025
From 30 September to 3 October, the tour visited three cities in the United Kingdom, involving physiotherapists and specialists who have chosen the M-Hi and HIRO TT laser systems.
Press - 07/10/2025
Recent research and pilot studies highlight the benefits of laser therapy in treating radiodermatitis and peripheral neuropathy induced by radiation and chemotherapy for breast cancer.